Benitec Biopharma (BNTC)
Develops BB-301, a ddRNAi genetic medicine for OPMD dysphagia.
$12.88
At close+0.57 (+4.63%)
Something off on this page? Send us feedback.
Next report
Sep 28, 2026
estimated · in 25 days
EPS estimate
−$0.26
Revenue estimate
—
Fiscal quarter
Q4 FY26
EPSReportedEstimate
Nov '24Feb '25May '25Sep '25Nov '25Feb '26May '26Sep '26
Reported−$0.48−$0.36−$0.24−$0.42−$0.22−$0.26−$0.24Pending
Estimate−$0.61−$1.00−$0.36−$0.28−$0.35−$0.23−$0.27−$0.26
Surprise+21.3%+64.0%+33.3%−50.0%+37.1%−13.0%+11.1%—
RevenueReportedEstimate
Nov '24Feb '25May '25Sep '25Nov '25Feb '26May '26Sep '26
Reported———$556.0K———Pending
Estimate——————$4.6M—
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Sep 2026 | −$0.26 | — | — |
| May 2026 | −$0.27 | −$0.24 | +11.1% |
| Feb 2026 | −$0.23 | −$0.26 | −13.0% |
| Nov 2025 | −$0.35 | −$0.22 | +37.1% |
| Sep 2025 | −$0.28 | −$0.42 | −50.0% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Sep 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Sep 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Sep 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Sep 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Sep 2020 | |||
| Aug 2020 | |||
| Jan 2020 | |||
| Dec 2019 | |||
| Aug 2019 | |||
| Apr 2019 | |||
| Feb 2019 | |||
| Dec 2018 | |||
| Sep 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| Jun 2017 | |||
| Feb 2017 | |||
| Dec 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Dec 2015 | |||
| Sep 2015 | |||
| Jun 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Sep 28, 2026 | −$0.26 | — | — | — | — | — | — |
| May 14, 2026 | −$0.27 | −$0.24 | +11.1% | $4.6M | — | — | −3.0% |
| Feb 12, 2026 | −$0.23 | −$0.26 | −13.0% | — | — | — | −8.5% |
| Nov 14, 2025 | −$0.35 | −$0.22 | +37.1% | — | — | — | +2.8% |
| Sep 22, 2025 | −$0.28 | −$0.42 | −50.0% | — | $556.0K | — | −2.2% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||||||
| May 14, 2025 | |||||||
| Feb 14, 2025 | |||||||
| Nov 14, 2024 | |||||||
| Sep 26, 2024 | |||||||
| May 13, 2024 | |||||||
| Feb 13, 2024 | |||||||
| Nov 13, 2023 | |||||||
| Sep 21, 2023 | |||||||
| May 15, 2023 | |||||||
| Feb 13, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Sep 2, 2022 | |||||||
| May 16, 2022 | |||||||
| Feb 14, 2022 | |||||||
| Nov 15, 2021 | |||||||
| Sep 20, 2021 | |||||||
| May 12, 2021 | |||||||
| Feb 9, 2021 | |||||||
| Nov 13, 2020 | |||||||
| Sep 23, 2020 | |||||||
| Aug 14, 2020 | |||||||
| Jan 31, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Aug 29, 2019 | |||||||
| Apr 24, 2019 | |||||||
| Feb 25, 2019 | |||||||
| Dec 31, 2018 | |||||||
| Sep 4, 2018 | |||||||
| May 31, 2018 | |||||||
| Feb 22, 2018 | |||||||
| Nov 29, 2017 | |||||||
| Aug 29, 2017 | |||||||
| Jun 30, 2017 | |||||||
| Feb 22, 2017 | |||||||
| Dec 31, 2016 | |||||||
| Aug 30, 2016 | |||||||
| May 24, 2016 | |||||||
| Feb 26, 2016 | |||||||
| Dec 31, 2015 | |||||||
| Sep 2, 2015 | |||||||
| Jun 30, 2015 | |||||||